|
|
Monitoring
Essentials for International
Medical Device Trials
Helen Colquhoun, MD
CEO Pleiad Devices
Recordings
US$249
|
 |
Purchase
a recording of this Audio Conference
The
FDA publishes warning letters on its website, and these are increasingly
concerned with the monitoring of medical device clinical studies.
It is clear that some device manufacturers are finding it difficult
to comply with the FDA's current guidance and regulations governing
the monitoring of medical device clinical trials. In Europe, monitoring
standards are similar but there is often a lack of clarity of
what is expected because the audience for the clinical trial application
(the competent authorities) and the CE marking dossier (the notified
bodies) is different.
In
this presentation, Dr. Helen Colquhoun will summarize the regulations
and official guidance governing the monitoring of medical device
clinical trials in the USA and EU. She will also provide the audience
with the essentials necessary to ensure compliance with these
regulations, including giving practical examples of what monitors
need to do at site. Dr. Colquhoun will also cover how to deal
with difficult investigators and sites that are unwilling to comply
with regulatory standards. A discussion will follow on the consequences
of non-compliance, as well as how to prepare for a monitoring
audit by the FDA. Dr. Colquhoun will also discuss how clinical
research departments need to be resourced to deal adequately with
monitoring demands. The presentation will be illustrated by real-life
examples.
This
audio conference will cover:
- The current
regulations governing the monitoring of medical device clinical
trials in the USA and EU
- What monitors
need to do at site to ensure compliance with these regulations
- The implications
for trial sponsors of non-compliance
- How to
prepare for an FDA monitoring audit
- How to
staff clinical research departments to adequately monitor studies
About
the speaker:
Helen
Colquhoun, MD holds degrees in Genetics and Medicine from the
University of Edinburgh and spent several years practicing clinical
medicine before entering the life science industry in 1988. Helen
spent seven years working with a major pharmaceutical company
before setting up as an independent consultant in 1995. Since
that time she has spent increasingly more time working with medical
device and drug delivery companies. In 2000 she co-founded the
Pleiad group of companies and is currently CEO of Pleiad Devices,
a clinical research organization based in the USA and Europe that
specializes in clinical research and regulatory support for medical
device companies. Helen runs Pleiad's North American operation
and is based in Cambridge, Massachusetts.
Who should
attend?
- Clinical
Research Managers
- Clinical
Research Associates
- Clinical
Research Monitors
- Regulatory
and Compliance Department Managers
- Regulatory
and Compliance Associates
Purchase
Options:
|